The role of genome sequencing in personalized breast cancer prevention

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 11, 2014, Pages 2322-2327

  Sieh, Weiva ^a   Rothstein, Joseph H ^a   McGuire, Valerie ^a   Whittemore, Alice S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; EFFECT SIZE; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC RISK; GENETIC VARIABILITY; GENOME; HIGH RISK POPULATION; HUMAN; MONOZYGOTIC TWINS; PERSONALIZED MEDICINE; POPULATION DISTRIBUTION; TWIN CONCORDANCE; BREAST NEOPLASMS; COMPARATIVE STUDY; DNA SEQUENCE; GENETIC SCREENING; GENETICS; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC TESTING; GENETIC VARIATION; GENOME; HUMANS; INDIVIDUALIZED MEDICINE; MODELS, STATISTICAL; RISK ASSESSMENT; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84920152558     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0559     Document Type: Article

References (19)

1. Roberts NJ, Vogelstein JT, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE. The predictive capacity of personal genome sequencing. Sci Transl Med 2012;4:133ra58.
2. Topol EJ. Comment on "the predictive capacity of personal genome sequencing". Sci Transl Med 2012;4:135le135.
3. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002;31:33-6.
4. Pharoah PD, Antoniou AC, Easton DF, Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 2008;358:2796-803.
5. Begg CB, Pike MC. Comment on "the predictive capacity of personal genome sequencing". Sci Transl Med 2012;4:135le133.
6. Bogdanova N, Feshchenko S, Schurmann P, Waltes R, Wieland B, Hillemanns P, et al. Nijmegen breakage syndrome mutations and risk of breast cancer. Int J Cancer 2008;122:802-6.
7. Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013;45:392-8.
8. Ghoussaini M, Pharoah PDP, Easton DF. Inherited genetic susceptibility to breast cancer. The beginning of the end or the end of the beginning? Am J Pathol 2013;183:1038-51.
9. Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M. Genetic susceptibility to breast cancer. Mol Oncol 2010;4:174-91.
10. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013;45:353-61.
11. Peng S, Lu B, Ruan W, Zhu Y, Sheng H, Lai M. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast Cancer Res Treat 2011;127:309-24.
12. Rennert G, Lejbkowicz F, Cohen I, Pinchev M, Rennert HS, Barnett- Griness O. MUTYH mutation carriers have increased breast cancer risk. Cancer 2012;118:1989-93.
13. Win AK, Lindor NM, Young JP, Macrae FA, Young GP,Williamson E, et al. Risks of primary extracolonic cancers following colorectal cancer in Lynch Syndrome. J Natl Cancer Inst 2012;104: 1363-72.
14. Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 2010;42:410-414.
15. Thompson ER, Boyle SE, Johnson J, Ryland GL, Sawyer S, Choong DYH, et al. Analysis of RDA51C germline mutations in high risk breast and ovarian cancer families and ovarian cancer patients. Hum Mutat 2010;33:95-99.
16. International Schizophrenia C, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-52.
17. Pashayan N, Hall A, Chowdhury S, Dent T, Pharoah PD, Burton H. Public health genomics and personalized prevention: lessons from the COGS project. J Intern Med 2013;274:451-6.
18. Li H, Beeghly-Fadiel A, Wen W, Lu W, Gao YT, Xiang YB, et al. Geneenvironment interactions for breast cancer risk among Chinese women: a report from the Shanghai breast cancer genetics study. Am J Epidemiol 2013;177:161-70.
19. Howlader N, Noone A, Krapcho M, Garshell J, Neyman N, Altekruse S, et al. SEER Cancer Statistics Review, 1975-2010. National Cancer Institute, Bethesda, MD. Based on November 2012 SEER data submission, posted to the SEER website, April 2013. Available from: http://seer.cancer.gov/csr/1975-2010/.